Puma Biotechnology

PBYINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$453.514 M

$8.91 +9.73%

Close of 7 Aug 2026

Revenue

$228.4M

#2258 by revenue

Earnings

$31.1M

#1743 by earnings

Shares outstanding

51,620,066

Latest filing cover page

P/E ratio

14.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#214Q32 BioQTTB$464.4M
#215Prothena Corp PublicPRTA$458.6M
#216Puma BiotechnologyPBYI$453.5M
#217RezoluteRZLT$451.6M
#218Larimar TherapeuticsLRMR$432.2M

Where these numbers come from

Share counts and financials for Puma Biotechnology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.